Royal DSM N.V. today provides the investment community with comparative quarterly figures for 2009 and Q1 2010.

These comparative figures reflect the reclassification of DSM Special Products from the Base Chemicals and Materials cluster to discontinued operations. This reclassification follows on from the announced agreement regarding the divestment of this business.

The comparative figures can be found in the annex to this press release and can also be downloaded from the Investors section on the DSM corporate website, www.dsm.com.

DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about €8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com.

For more information: